Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90201-90250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
PHASE4Recruiting
16,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition7 sponsors1 location
NCT05235009
LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in Asymptomatic Adults (LEV87A)
N/ARecruiting
9,170 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04924088
Medical-legal Partnerships to Prevent Evictions and Homelessness Among Veterans
NARecruiting
300 participants
Started: Feb 1, 2022 · Completed: Oct 30, 2026
2 conditions2 sponsors1 location
NCT05559450
Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL
PHASE2Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
1 condition7 sponsors1 location
NCT05368987
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
NARecruiting
250 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05216809
Oral 'Breath Test' to Measure Anabolic Sensitivity in Young and Older Adults at Different Activity Levels
NARecruiting
32 participants
Started: Feb 1, 2022 · Completed: Mar 31, 2024
5 conditions1 sponsor1 location
NCT05235867
Secretin in Refeeding
N/ARecruiting
10 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04770870
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
NARecruiting
232 participants
Started: Feb 1, 2022 · Completed: Apr 30, 2029
3 conditions1 sponsor10 locations
NCT05493800
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
PHASE2Active, not recruiting
60 participants
Started: Feb 1, 2022 · Completed: Dec 30, 2024
4 conditions1 sponsor2 locations
NCT05214261
Laparoscopic-guided TAP Block vs Epidural Analgesia
NARecruiting
210 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05021237
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer
PHASE2Active, not recruiting
12 participants
Started: Feb 1, 2022 · Completed: Aug 31, 2028
4 conditions2 sponsors1 location
NCT07146256
Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry
N/ARecruiting
300 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2030
1 condition2 sponsors1 location
NCT04933370
Neuromodulation Parameter Efficacy
NARecruiting
20 participants
Started: Feb 1, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05169268
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
N/ARecruiting
10 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05503667
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
PHASE2Recruiting
96 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05953077
The Effect of Prior Learning on Treatment of Morpheme Errors
NARecruiting
32 participants
Started: Feb 1, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05020587
Consulting After Combat: Interviewing Veterans to Develop a Therapy to Restore Functioning and Reintegration After Moral Injury Events
NAActive, not recruiting
12 participants
Started: Feb 1, 2022 · Completed: Oct 30, 2026
2 conditions1 sponsor1 location
NCT05241249
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
PHASE2Recruiting
37 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05146609
Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population
NARecruiting
1,384 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT04561986
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
PHASE3Recruiting
50 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2028
1 condition9 sponsors8 locations
NCT06224244
External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients
PHASE2Active, not recruiting
180 participants
Started: Feb 1, 2022 · Completed: Apr 1, 2027
2 conditions1 sponsor1 location
NCT05142683
Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial
NARecruiting
300 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2027
1 condition3 sponsors1 location
NCT05262023
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
PHASE1/PHASE2Recruiting
106 participants
Started: Feb 1, 2022 · Completed: Nov 30, 2028
1 condition2 sponsors32 locations
NCT05138380
Hip Osteoarthritis and Foot Orthoses Trial (HOOT)
NARecruiting
28 participants
Started: Feb 1, 2022 · Completed: Oct 26, 2025
1 condition1 sponsor1 location
NCT06961474
Effectiveness of Treatments for Cirrhosis With Varicose Veins
N/AActive, not recruiting
1,900 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05290805
Optimized CT-imaging Protocol in VA-ECMO Patients After CPR
NAActive, not recruiting
50 participants
Started: Feb 1, 2022 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT05282381
Evaluation of Regret in Kidney Transplantation
N/ARecruiting
250 participants
Started: Feb 1, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05124457
DETERMINE: Detemir vs NPH
PHASE2Recruiting
336 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06533943
"Blue-green Space Physical Activity: the Parco Del Mare Study"
NARecruiting
30 participants
Started: Feb 1, 2022 · Completed: Dec 20, 2024
3 conditions1 sponsor1 location
NCT05735067
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
N/AActive, not recruiting
138 participants
Started: Feb 1, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT04461301
Multimodal Prehabilitation for Surgery in the Elderly: a Randomised, Prospective, Multicenter, Multidisciplinary Trial
NARecruiting
466 participants
Started: Feb 1, 2022 · Completed: Dec 30, 2026
2 conditions3 sponsors1 location
NCT05321355
Mainz Register of Patients With Sleep Disorders
N/ARecruiting
500 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2030
9 conditions1 sponsor1 location
NCT04820335
Promoting Independence With Compensatory Cognitive Rehabilitation
NARecruiting
65 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06191367
Effect of Aerobic Exercises Versus Incentive Spirometer Device on Post-covid Pulmonary Fibrosis Patients
NAActive, not recruiting
45 participants
Started: Feb 1, 2022 · Completed: Feb 29, 2024
2 conditions2 sponsors1 location
NCT05332626
Lactobacillus Acidophilus and Postmenopausal Osteoporosis Women
NAActive, not recruiting
60 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT05126823
Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients
NARecruiting
120 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05779319
1000 Eyes Lens Biometry Study: Artificial Intelligence for Intraocular Lens Power Calculation
N/ARecruiting
1,000 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors1 location
NCT05253495
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
PHASE2Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2028
2 conditions1 sponsor3 locations
NCT06220097
Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies
PHASE2Active, not recruiting
28 participants
Started: Feb 1, 2022 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT05176977
Homeless Veterans and Peer Whole Health Coaching
NAActive, not recruiting
177 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
4 conditions1 sponsor3 locations
NCT05760664
Exercises Directed To Dynamic Stiffness Of The Thoracolumbar Region And Performance Of Amateur Runners
NARecruiting
99 participants
Started: Feb 1, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT05425381
Improving Social, Emotional, Behavioral, and Academic Functioning
NAEnrolling by invitation
1,208 participants
Started: Feb 1, 2022 · Completed: Dec 15, 2025
3 conditions4 sponsors2 locations
NCT05282654
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
NARecruiting
1,300 participants
Started: Feb 1, 2022 · Completed: Oct 15, 2026
2 conditions2 sponsors2 locations
NCT06097247
Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia Nervosa
N/AActive, not recruiting
60 participants
Started: Feb 1, 2022 · Completed: Aug 1, 2027
3 conditions2 sponsors1 location
NCT03175718
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients
NARecruiting
291 participants
Started: Feb 1, 2022 · Completed: Apr 28, 2026
2 conditions1 sponsor2 locations
NCT05146362
Vermont RETAIN Impact Evaluation
NARecruiting
2,040 participants
Started: Feb 1, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05242055
Integrated Diagnosis and Treatment of CKD on Outcomes
N/ARecruiting
1,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT05315596
Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery
N/AEnrolling by invitation
1,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2030
7 conditions16 sponsors16 locations
NCT04773470
Implementation of FEES in Spinal Muscle Atrophy
NARecruiting
79 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05059210
Primary Care Implementation and Evaluation of Coach McLungs
NAActive, not recruiting
19 participants
Started: Feb 1, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location